REQUEST A DEMO
Total
USD $0.00
Search more companies

Dr. Szabo Lajosne Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: Dr. Szabo Lajosne Kereskedelmi Bt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Dr. Szabo Lajosne Bt. is based in Hungary. The head office is in Mernye. It operates in the Pharmacies and Drug Stores industry. Dr. Szabo Lajosne Bt. was incorporated on January 01, 1997. Dr. Szabo Lajosne Bt. currently employs 3 (2024) people. The latest financial highlights indicate a net sales revenue increase of 19.92% in 2023. A growth of 7.91% was recorded in its total assets. In 2023, Dr. Szabo Lajosne Bt.’s net profit margin decreased by 0.2%.

Headquarters
Petofi u.4.
Mernye; Somogy; Postal Code: 7453

Contact Details: Purchase the Dr. Szabo Lajosne Bt. report to view the information.

Basic Information
Total Employees:
Purchase the Dr. Szabo Lajosne Bt. report to view the information.
Outstanding Shares:
Purchase the Dr. Szabo Lajosne Bt. report to view the information.
Registered Capital:
Purchase the Dr. Szabo Lajosne Bt. report to view the information.
Incorporation Date:
January 01, 1997
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Dr. Szabo Lajosne Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
19.92%
Total operating revenue
20.29%
Operating profit (EBIT)
15.15%
EBITDA
12.39%
Net Profit (Loss) for the Period
13.55%
Total assets
7.91%
Total equity
38.93%
Operating Profit Margin (ROS)
-0.17%
Net Profit Margin
-0.2%
Return on Equity (ROE)
-6.27%
Quick Ratio
-0.23%
Cash Ratio
-0.35%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?